Mytesi and Prezista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 16 people who take Mytesi and Prezista. Common interactions include anxiety among females, and emotional distress among males.

The phase IV clinical study analyzes what interactions people who take Mytesi and Prezista have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 28, 2023

16 people who take Mytesi and Prezista together, and have interactions are studied.


What is Mytesi?

Mytesi has active ingredients of crofelemer. Currently, eHealthMe is studying from 117 Mytesi users.

What is Prezista?

Prezista has active ingredients of darunavir ethanolate. It is used in hiv infection. Currently, eHealthMe is studying from 11,829 Prezista users.

Number of Mytesi and Prezista reports submitted per year:

Mytesi and Prezista drug interactions.

Common Mytesi and Prezista drug interactions by gender *:

female:

  1. Anxiety
  2. Arthralgia
  3. Depression
  4. Emotional distress
  5. Fracture
  6. Fractured sacrum
  7. Gait disturbance
  8. Hip fracture
  9. Joint dislocation
  10. Joint injury

male:

  1. Emotional distress
  2. Pain
  3. Osteoporosis
  4. Fanconi syndrome acquired
  5. Fracture
  6. Hyperparathyroidism secondary
  7. Anaemia
  8. Azotaemia
  9. Hyperphosphataemia
  10. Hyponatraemia


Common Mytesi and Prezista drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anxiety
  2. Arthralgia
  3. Depression
  4. Emotional distress
  5. Fracture
  6. Fractured sacrum
  7. Gait disturbance
  8. Hip fracture
  9. Joint dislocation
  10. Joint injury

40-49:

n/a

50-59:

  1. Emotional distress
  2. Pain
  3. Chronic kidney disease
  4. Anhedonia
  5. Anxiety
  6. Renal failure
  7. Renal tubular necrosis
  8. Bone density decreased
  9. Hypokalaemia
  10. Osteonecrosis

60+:

  1. Blood glucose decreased
  2. Blood pressure decreased
  3. Renal disorder
  4. Renal impairment
  5. Contusion
  6. Dehydration
  7. Dizziness
  8. Drug hypersensitivity
  9. Fall
  10. Gait disturbance

Common conditions people have *:

  1. Stress And Anxiety: 2 people, 12.50%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 12.50%
  3. Asthma: 2 people, 12.50%
  4. Bacterial Infection: 2 people, 12.50%
  5. Chest Pain: 2 people, 12.50%
  6. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 2 people, 12.50%
  7. Depression: 2 people, 12.50%
  8. Diarrhea: 2 people, 12.50%
  9. Fungal Infection: 2 people, 12.50%
  10. Gastric Disorder (disease of stomach): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Mytesi and Prezista?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Browse interactions between Mytesi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prezista drug interactions:

Browse interactions between Prezista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on crofelemer and darunavir ethanolate (the active ingredients of Mytesi and Prezista, respectively), and Mytesi and Prezista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Mytesi and Prezista.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: